13 research outputs found
Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses
CONCLUSION: TA-8995 dose dependently increased not only total and non-ABCAl-specific CEC but also ABCAl-specific CEC and preBeta-1 HDL particle levels. These findings suggest that TA-8995 not only increases HDL-C levels but also promotes functional properties of HDL particles. This CETP inhibitor driven preBeta-1 HDL increase is an important predictor of both ABCA1 and total CEC increase, independent of HDL-C increase. Whether these changes in HDL particle composition and functionality have a beneficial effect on cardiovascular outcome requires formal testing in a cardiovascular outcome trial. (C) 2016 National Lipid Association. All rights reserved.Cellular mechanisms in basic and clinical gastroenterology and hepatolog
Early origins of lung disease: Towards an interdisciplinary approach
The prenatal and perinatal environments can have profound effects on the development of
chronic inflammatory diseases. However, mechanistic insight into how the early-life microenvironment
can impact upon development of the lung and immune system and consequent initiation and progression
of respiratory diseases is still emerging. Recent studies investigating the developmental origins of lung
diseases have started to delineate the effects of early-life changes in the lung, environmental exposures and
immune maturation on the development of childhood and adult lung diseases. While the influencing
factors have been described and studied in mostly animal models, it remains challenging to pinpoint
exactly which factors and at which time point are detrimental in lung development leading to respiratory
disease later in life. To advance our understanding of early origins of chronic lung disease and to allow for
proper dissemination and application of this knowledge, we propose four major focus areas: 1) policy and
education; 2) clinical assessment; 3) basic and translational research; and 4) infrastructure and tools, and
discuss future directions for advancement. This review is a follow-up of the discussions at the European
Respiratory Society Research Seminar âEarly origins of lung disease: towards an interdisciplinary
approachâ (Lisbon, Portugal, November 2019)
Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits : A Multi-Ethnic Meta-Analysis of 45,891 Individuals
J. Kaprio, S. Ripatti ja M.-L. Lokki työryhmien jÀseniÀ.Peer reviewe
Growth versus inflammation : lung development after antenatal inflammation and corticosteroids
In the Western world 5-13% of all children are born early, before 37 weeks of pregnancy duration. Premature birth is often caused by a bacterial infection in the uterus. The most common disorder in these babies is bronchopulmonary dysplasia (BPD), an incurable disorder in the lung growth as a result of which they donât get sufficient oxygen in their body. So, it is known that uterus infections often lead to the development of BPD, but how this exactly happens is not clear. This dissertation studies how bacterial infections influence the lung development, so that in the future new therapies can be developed to cure or even prevent BPD
Early career members at the ers lung science conference: cell-matrix interactions in lung disease and regeneration
Simulation analysis of formycin 5?-monophosphate analog substrates in the ricin A-chain active site
Mixed ab initio and semiempirical study of hydrogen-terminated finite germanium nanowires
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes
OBJECTIVE - Proinsulin is a precursor of mature insulin and C-peptide. Higher circulating proinsulin levels are associated with impaired b-cell function, raised glucose levels, insulin resistance, and type 2 diabetes (T2D). Studies of the insulin processing pathway could provide new insights about T2D pathophysiology. RESEARCH DESIGN AND METHODS - We have conducted a meta-analysis of genome-wide association tests of ;2.5 million genotyped or imputed single nucleotide polymorphisms (SNPs) and fasting proinsulin levels in 10,701 nondiabetic adults of European ancestry, with follow-up of 23 loci in up to 16,378 individuals, using additive genetic models adjusted for age, sex, fasting insulin, and study-specific covariates. RESULTS - Nine SNPs at eight loci were associated with proinsulin levels (P < 5 Ă 10-8). Two loci (LARP6 and SGSM2) have not been previously related to metabolic traits, one (MADD) has been associated with fasting glucose, one (PCSK1) has been implicated in obesity, and four (TCF7L2, SLC30A8, VPS13C/ C2CD4A/B, and ARAP1, formerly CENTD2) increase T2D risk. The proinsulin-raising allele of ARAP1 was associated with a lower fasting glucose (P = 1.7 3 10-4), improved b-cell function (P = 1.1 Ă 10-5), and lower risk of T2D (odds ratio 0.88; P = 7.8 Ă 10-6). Notably, PCSK1 encodes the protein prohormone convertase 1/3, the first enzyme in the insulin processing pathway. A genotype score composed of the nine proinsulin-raising alleles was not associated with coronary disease in two large case-control datasets. CONCLUSIONS - We have identified nine genetic variants associated with fasting proinsulin. Our findings illuminate the biology underlying glucose homeostasis and T2D development in humans and argue against a direct role of proinsulin in coronary artery disease pathogenesis